Antipsychotics · Second-Generation (Atypical)
Clozapine
Brand: Clozaril, FazaClo (orally disintegrating), Versacloz (oral suspension)
Second-generation (atypical) antipsychotic
15 cards
Want adaptive tracking?
Create a free account and every review is tracked with spaced repetition. Cards you struggle with come back sooner, and your weak areas surface automatically.
Create free account →Card Topics
core (1)risk (6)monitoring (3)interaction (1)trap (2)dosing (1)population (1)
All Cards
1.Clozapine: two FDA indications.
2.Clozapine: life-threatening hematologic risk and incidence.
3.Clozapine ANC monitoring schedule.
4.Clozapine ANC thresholds for action.
5.Clozapine myocarditis: when does risk peak and how to monitor.
6.Clozapine: potentially fatal GI complication.
7.Clozapine CYP1A2 interactions: smoking and one SSRI to avoid.
8.Clozapine seizure risk.
9.Can any other antipsychotic replace clozapine for treatment-resistant schizophrenia?
10.Clozapine target dose and therapeutic trough level.
11.Clozapine sialorrhea: frequency and management.
12.Clozapine metabolic monitoring.
13.Persistent sinus tachycardia on clozapine — benign or dangerous?
14.Clozapine patient admitted to hospital, stops smoking. What to do?
15.Benign ethnic neutropenia (BEN) and clozapine.
Want the full clinical reference for this medication?
Read the Clozapine reference page →